Cell Prolif. 2024 Dec;57(12):e13767. doi: 10.1111/cpr.13767. Epub 2024 Oct 20.
J. Zhu , WT. Gu , and C. Yu , "MATN1-AS1 Promotes Glioma Progression by Functioning as ceRNA of miR-200b/c/429 to Regulate CHD1 Expression," Cell Proliferation 53, no. 1 (2020): e12700. https://doi.org/10.1111/cpr.12700. The above article, published online on 30 October 2019, in Wiley Online Library (wileyonlinelibrary.com), and has been retracted by agreement between the authors; the journal Deputy Editor, Yunfeng Lin; and John Wiley & Sons Ltd. The authors contacted the journal and reported that they had detected mistakes in the figures that compromised the validity of the article's results and requested a retraction. In addition, a report from a third party found duplications between Figures 2E and 2C with other articles by different authors, each of which describe different experimental conditions. Following further correspondence, the authors acknowledged these duplications and have stated that they cannot confirm the authenticity of the data. The retraction has been agreed to because the duplications of images across different articles fundamentally compromises the conclusions and results presented in the article.
朱杰、顾文涛、于超,“MATN1-AS1作为miR-200b/c/429的ceRNA调控CHD1表达促进胶质瘤进展”,《细胞增殖》第53卷,第1期(2020年):e12700。https://doi.org/10.1111/cpr.12700。上述文章于2019年10月30日在线发表于威利在线图书馆(wileyonlinelibrary.com),现已根据作者、期刊副主编林云峰以及约翰·威利父子有限公司的协议撤回。作者联系期刊并报告称,他们发现图中存在错误,这些错误损害了文章结果的有效性,并要求撤回。此外,第三方报告发现图2E和2C与其他不同作者的文章存在重复,这些文章描述的是不同的实验条件。经过进一步沟通,作者承认了这些重复,并表示无法确认数据的真实性。同意撤回是因为不同文章间图像的重复从根本上损害了文章所呈现的结论和结果。